Journal of Commercial Biotechnology — May 2011 issue now available
The May 2011 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:
Volume 17, Issue 2
Editorial
Building biotechnology in Okinawa | |
Yali Friedman |
Commentary
Startup America: What it includes and opportunities for innovators | |
David B Orange |
Singapore – Home base for expansion in Asia | |
Kian-Teik Beh |
Traditional ecological knowledge: Impact on commercial health | |
Mohammadali Khalvati, Ikway (Yvonne Fulton) Michine, Wabiska (Zane Bell) Mukwa, Mary Jane Metatawabin |
Articles
The growing importance of incorporating US payers into biotechnology drug development decision-making | |
Sarah Collins |
Anticipating opportunities in industrial biotechnology: Sizing the market and growth scenarios | |
Peter J Nieuwenhuizen, David Lyon |
Founding angels as early stage investment model to foster biotechnology start-ups | |
Gunter Festel |
The economic potential of plant-made pharmaceuticals in the manufacture of biologic pharmaceuticals | |
James Kaufman, Nicholas Kalaitzandonakes |
From the Classroom
Developing graduate skills for the United Kingdom’s commercial life science sector: Experiences from the ORBIS internship programme | |
James Gazzard |
Legal and Regulatory Updates
EU Legal and Regulatory Update | |
Gerry Kamstra |
Impact of recent IP caselaw on biomarkers and personalized medicine | |
David A Gass |
Licensing issues in today’s bankruptcy world | |
Michael Schein, Brandon J Fleischman |
Limitation of gene patents to functioning DNA | |
Philip Webber |
Book Reviews
Chronicling the development of myozyme: The Cure and Chasing Miracles | |
Derek J Francis |
Anatomy of a Patent Case | |
Michael G Sullivan |
Comments are closed.